Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
India plans a major pharma licensing overhaul with a separate wholesale licence for bulk drugs and APIs to improve traceability and safety. This move follows global scrutiny over contaminated cough syrups and aims to regulate a $50-billion market.
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
Aurobindo Pharma strengthens its domestic formulations market with a ₹325 crore acquisition of Khandelwal Laboratories' non-oncology business. The deal includes 23 established brands and boosts presence in pain & anti-infective segments. Read more.
US President Donald Trump secures agreements with nine major pharmaceutical companies to reduce Medicaid and cash-pay drug prices, aiming to align US costs with other wealthy nations. Details inside.
Pfizer India and Cipla announce a 5-year partnership. Cipla will exclusively market and distribute four key Pfizer brands in India, aiming to expand patient reach nationwide. Read details.
Takeda's oral drug zasocitinib, discovered using AI, showed high efficacy in psoriasis trials, boosting its stock. Could be a game-changer for millions. Read the full analysis.
Sun Pharmaceutical shares fell over 3% after a US FDA inspection at its Baska plant. The inspection concluded with 3 observations. Get the full details on the market impact and company's response.
Odisha CM Mohan Majhi positions state as top pharma & medical devices investment destination. New policy & parks attract Rs 7,043 crore proposals, 45 MoUs signed. Read more.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Corona Remedies IPO subscription opens Dec 8. Price band fixed at ₹1,008-₹1,062 per share. The ₹655.37 crore offer is a complete OFS. Check dates, lot size, and company details.
Granules India establishes two advanced research centres at IIT Hyderabad's Technology Research Park, focusing on peptide development and particle engineering to enhance global pharma innovation.
The UK's NHS will pay 25% more for innovative drugs in a new US trade deal, costing £3bn over three years. In return, UK pharma exports to the US avoid hefty tariffs. Read the full analysis.
The US extends a critical tariff exemption for UK pharmaceutical and medical technology imports for three years, supporting supply chains and public health. Read the full analysis.
Mumbai's Wockhardt creates history as USFDA accepts its New Drug Application for antibiotic Zaynich, a first for an Indian firm. Shares surge 19%. Read more.
Wockhardt shares surged 19.3% after US FDA accepted its New Drug Application for Zaynich, a first-in-class antibiotic. This marks a historic first for an Indian pharma company's New Chemical Entity.
A 51-year-old Mumbai businesswoman was held at gunpoint, stripped and threatened by pharmaceutical company executives. Mumbai Police registers case under multiple sections.
Kolkata Police arrests Bhola Prasad, father of absconding pharmaceutical dealer Shubham Jaiswal, in UP's multi-state codeine trafficking investigation. Read the full story.
Uttar Pradesh authorities uncover massive pharmaceutical diversion network smuggling codeine-based cough syrups as narcotics across 7 states and borders. 87 firms face FIRs in chilling organized crime operation.
NCB obtains non-bailable warrants against Digital Vision owners in massive ₹600 crore drug diversion case. Key accused involved in international pharmaceutical fraud uncovered in Himachal Pradesh.
Uttar Pradesh government intensifies crackdown on cough syrup smuggling, registers cases against 12 pharmaceutical companies. Investigation reveals interstate smuggling network.
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced single-use systems and filtration technologies.
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced drug delivery systems and filtration technologies.
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma shares list on BSE and NSE today after 93.72 times subscription. Grey market signals 20% premium debut. Full details on pricing and investor response.
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.